Items of recent pandemic news: A new, wildly divergent SARS-CoV-2 strain in deer; mental health sequelae in Covid-19 survivors; an update on locating a supply of Paxlovid; new CDC masking guidance; and more. Plus a Ukrainian frippery. Quote of the … Continue reading →
Items of recent pandemic news: Omicron boosters prove unhelpful; wastewater surveillance comes into its own; Covid-19 causes long-term heart and circulatory issues; results from the first SARS-CoV-2 challenge trial published; and more. Plus two fripperies. Quote of the week Eric … Continue reading →
Items of recent pandemic news: Monitoring sewage for Covid early warning; therapeutics in short supply; a variant of little concern; antigen tests may miss early infectivity; Pfizer boost authorized for 12-15-year-olds; and more. Plus a frippery. Quote of the week … Continue reading →
Items of recent pandemic news: A common cold coronavirus may have mixed into Omicron; AstraZeneca’s long-lasting injectable antibody gets authorized; SARS-CoV-2 can infect fat cells; what we tentatively know about Omicron; and much more. Plus a frippery. Quotes of the … Continue reading →
Items of recent pandemic news: Deer may provide a SARS-CoV-2 reservior; OSHA promulgates rules implementing the Biden administration’s workplace vaccine mandate; and a strong showing for Pfizer’s oral medication against SARS-CoV-2. Plus a frippery. Pfizer’s anti-Covid pill shows strong results … Continue reading →
Items of recent pandemic news you may have missed: Moderna kids’ trial is enrolling; a new variant seen in Polish mink; a rapid-testing approach to in-person schooling; the tidal wave of vaccine mandates; and more. Plus a frippery. 1. Vaccination … Continue reading →
Items of recent pandemic news you may have missed: The animals sold in Wuhan’s wet markets; animal reservoirs for SARS-CoV-2; and animal vaccinations. Plus the usual frippery, this one animal-themed as well. A vaccine for zoo animals We have discussed … Continue reading →
Herewith three items of recent pandemic news: More studies on mixing vaccine doses; the FDA extends Pfizer’s authorization to ages 12+; and acknowledgement from the CDC that this virus is airborne. Plus news briefs and a frippery. It is indeed … Continue reading →
Herewith three items of pandemic news you may have missed recently: Covid-19 can damage the brain without infecting it; what’s up with the blood clots; and the FDA shuts down Emergent’s Baltimore operation. Plus news briefs and a frippery. FDA … Continue reading →
Herewith three items of pandemic news you may have missed: Vitamin D levels vs. infection probability in Black people; variant viruses infecting animals; and the roller coaster that is AstraZeneca’s Phase III results announcement. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed recently: Infected gorillas; inhalable therapies and prophylactics; and the greater difficulty of testing new vaccine candidates once some have been authorized. Plus the accustomed frippery. After authorized vaccines, testing later … Continue reading →
Herewith three items of pandemic news you may have missed recently: Less accurate pulse oximeter readings for Black patients; the spreading mink pandemic; and a marketing name for the Pfizer / BioNTech vaccine. Plus the accustomed frippery. Comirnaty You may … Continue reading →
Herewith three items of pandemic news you may have missed recently: FDA investigating allergic reactions to the first vaccine; the susceptibility of pigs; and the give-and-take among sleep, melatonin, and Covid-19. Plus the usual frippery. Sleep The Atlantic has a … Continue reading →
Herewith three items of pandemic news you may have missed recently: A wild mink in Utah has turned up infected; and two possibilities for finding that we may have more vaccine than we thought we did. Plus two fripperies. Just … Continue reading →
Herewith three items of pandemic news you may have missed recently: Zombie mink; dogs sniffing for Covid; and the mounting complications of AstraZeneca’s Phase III trials. Plus the usual frippery. AstraZenica Agonistes What a difference four days makes. After AstraZeneca … Continue reading →
